help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hyman, B. T.
Right arrow Articles by Reiter, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hyman, B. T.
Right arrow Articles by Reiter, J.

American Journal of Pathology, Vol 144, 565-572, Copyright © 1994 by American Society for Investigative Pathology


REGULAR ARTICLES

Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease

BT Hyman, TE Elvhage and J Reiter
Neurology Service, Massachusetts General Hospital, Boston 02114.

MAP kinases (MAPK) are a family of serine/threonine (Ser/Thr) kinases that link cell surface signals to changes in enzyme activity and gene expression. They are the products of the newly described gene family referred to as extracellular signal regulated kinases (ERKs). Moreover, MAPKs phosphorylate tau in vitro at Ser/Thr Proline sites, generating a multiply phosphorylated tau protein that is similar to the hyperphosphorylated tau found in Alzheimer neurofibrillary tangles (NFTs). We studied MAPK immunoreactivity and in situ hybridization patterns of the two major genes that comprise MAPK activity, ERK1 and ERK2, in the human hippocampal formation. Our goal was to determine whether the pattern of ERK expression is consistent with the hypothesis that MAPKs contribute to NFT formation. ERK1 mRNA is present in small amounts and confined primarily to dentate gyrus granule cells. ERK2 mRNA, by contrast, gives a much stronger hybridization signal and is present in dentate gyrus granule cells and pyramidal cells throughout all hippocampal subfields and adjacent temporal neocortex. Quantitative measures of ERK2 mRNA reveal that NFT-bearing neurons contain approximately 15% less ERK2 mRNA than nearest neighbors that do not contain NFT. NFT-bearing neurons contain approximately 25% less polyA mRNA, suggesting a relative preservation of ERK2 mRNA even in metabolically compromised cells. MAPK immunoreactivity (which represents both ERK1 and ERK2) is seen in neuronal soma, dendrites, axons, and in reactive astrocytes. In Alzheimer's disease, neurons that contain NFTs are also MAPK immunoreactive, but neurons that contain the highest amounts of MAPK immunoreactivity are not necessarily vulnerable for NFT. MAPK immunoreactivity is present in the same neurons as NFT and in the same subcellular compartments as tau, supporting a role for MAPKs in tau phosphorylation in Alzheimer's disease. However, the presence of ERK immunoreactivity is not sufficient to predispose neurons to NFT formation.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
F. M. Harris, W. J. Brecht, Q. Xu, R. W. Mahley, and Y. Huang
Increased tau Phosphorylation in Apolipoprotein E4 Transgenic Mice Is Associated with Activation of Extracellular Signal-regulated Kinase: MODULATION BY ZINC
J. Biol. Chem., October 22, 2004; 279(43): 44795 - 44801.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. M. Harris, I. Tesseur, W. J. Brecht, Q. Xu, K. Mullendorff, S. Chang, T. Wyss-Coray, R. W. Mahley, and Y. Huang
Astroglial Regulation of Apolipoprotein E Expression in Neuronal Cells: IMPLICATIONS FOR ALZHEIMER'S DISEASE
J. Biol. Chem., January 30, 2004; 279(5): 3862 - 3868.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Russo, V. Dolcini, S. Salis, V. Venezia, N. Zambrano, T. Russo, and G. Schettini
Signal Transduction through Tyrosine-phosphorylated C-terminal Fragments of Amyloid Precursor Protein via an Enhanced Interaction with Shc/Grb2 Adaptor Proteins in Reactive Astrocytes of Alzheimer's Disease Brain
J. Biol. Chem., September 13, 2002; 277(38): 35282 - 35288.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
M. A. HEBERT and J. P. O'CALLAGHAN
Protein Phosphorylation Cascades Associated with Methamphetamine-induced Glial Activation
Ann. N.Y. Acad. Sci., September 1, 2000; 914(1): 238 - 262.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. W. Mandell, I. M. Hussaini, M. Zecevic, M. J. Weber, and S. R. VandenBerg
In Situ Visualization of Intratumor Growth Factor Signaling : Immunohistochemical Localization of Activated ERK/MAP Kinase in Glial Neoplasms
Am. J. Pathol., November 1, 1998; 153(5): 1411 - 1423.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Luo, J. D. Bond, and V. M. Ingram
Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases
PNAS, September 2, 1997; 94(18): 9705 - 9710.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Society for Investigative Pathology.